Literature DB >> 21145396

Proteasomal dysfunction in aging and Huntington disease.

Xiao-Jiang Li1, Shihua Li.   

Abstract

Protein degradation plays a central role in many cellular functions. Misfolded and damaged proteins are removed from the cells to avoid toxicity. Eukaryotic cells have two main routes for clearing misfolded or toxic proteins: the ubiquitin-proteasome and autophagy-lysosome pathways. The ubiquitin-proteasome system (UPS) is ubiquitously present in the cytoplasm, nucleus, and various subcellular regions whereas autophagy predominantly functions in the cytoplasm. The activity of the UPS often remains at a high level, whereas basal autophagy constitutively occurs at low levels in cells for the performance of homeostatic functions. Because of the presence of the UPS in the nucleus, the UPS function may be more important for clearing misfolded proteins in the nucleus. Polyglutamine diseases, including Huntington disease (HD), show the age-dependent neurological symptoms and the accumulation of misfolded proteins that are often found in the nucleus. The selective neuropathology in HD is also found to associate with the preferential accumulation of the disease protein huntingtin in neuronal cells. Although it is clear that the UPS is important for clearing mutant huntingtin, it remains unclear whether aging or HD affects the capacity of neuronal UPS to remove toxic and misfolded proteins. In this review, we focus on the relationship between the UPS function and aging as well as Huntington disease. We also discuss findings that suggest that aging is a more important factor that can negatively impact the function of the UPS. This article is part of a Special Issue entitled "Autophagy and protein degradation in neurological diseases."
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21145396      PMCID: PMC3090713          DOI: 10.1016/j.nbd.2010.11.018

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  53 in total

Review 1.  Proteolysis: from the lysosome to ubiquitin and the proteasome.

Authors:  Aaron Ciechanover
Journal:  Nat Rev Mol Cell Biol       Date:  2005-01       Impact factor: 94.444

Review 2.  The proteasome and its role in nuclear protein maintenance.

Authors:  Nicolle Bader; Tobias Jung; Tilman Grune
Journal:  Exp Gerontol       Date:  2007-04-10       Impact factor: 4.032

Review 3.  Proteasome function in aging and oxidative stress: implications in protein maintenance failure.

Authors:  Luc Farout; Bertrand Friguet
Journal:  Antioxid Redox Signal       Date:  2006 Jan-Feb       Impact factor: 8.401

Review 4.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

5.  ATP-dependent incorporation of 20S protease into the 26S complex that degrades proteins conjugated to ubiquitin.

Authors:  E Eytan; D Ganoth; T Armon; A Hershko
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

6.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

Authors:  M DiFiglia; E Sapp; K O Chase; S W Davies; G P Bates; J P Vonsattel; N Aronin
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

Review 7.  Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies.

Authors:  M Borrell-Pagès; D Zala; S Humbert; F Saudou
Journal:  Cell Mol Life Sci       Date:  2006-11       Impact factor: 9.261

8.  Inhibiting the ubiquitin-proteasome system leads to preferential accumulation of toxic N-terminal mutant huntingtin fragments.

Authors:  Xiang Li; Chuan-En Wang; Shanshan Huang; Xingshun Xu; Xiao-Jiang Li; He Li; Shihua Li
Journal:  Hum Mol Genet       Date:  2010-03-30       Impact factor: 6.150

9.  Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation.

Authors:  Aaron B Bowman; Seung-Yun Yoo; Nico P Dantuma; Huda Y Zoghbi
Journal:  Hum Mol Genet       Date:  2005-01-20       Impact factor: 6.150

10.  Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target.

Authors:  John S Bett; Geoffrey M Goellner; Ben Woodman; Gregory Pratt; Martin Rechsteiner; Gillian P Bates
Journal:  Hum Mol Genet       Date:  2005-11-25       Impact factor: 6.150

View more
  50 in total

Review 1.  Engineered antibody therapies to counteract mutant huntingtin and related toxic intracellular proteins.

Authors:  David C Butler; Julie A McLear; Anne Messer
Journal:  Prog Neurobiol       Date:  2011-11-18       Impact factor: 11.685

2.  RTP801 Is Involved in Mutant Huntingtin-Induced Cell Death.

Authors:  Núria Martín-Flores; Joan Romaní-Aumedes; Laura Rué; Mercè Canal; Phil Sanders; Marco Straccia; Nicholas D Allen; Jordi Alberch; Josep M Canals; Esther Pérez-Navarro; Cristina Malagelada
Journal:  Mol Neurobiol       Date:  2015-04-16       Impact factor: 5.590

3.  Sulforaphane enhances proteasomal and autophagic activities in mice and is a potential therapeutic reagent for Huntington's disease.

Authors:  Yanying Liu; Casey L Hettinger; Dong Zhang; Khosrow Rezvani; Xuejun Wang; Hongmin Wang
Journal:  J Neurochem       Date:  2014-01-18       Impact factor: 5.372

Review 4.  Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities.

Authors:  Rachel J Harding; Yu-Feng Tong
Journal:  Acta Pharmacol Sin       Date:  2018-04-05       Impact factor: 6.150

Review 5.  Emerging roles of molecular chaperones and co-chaperones in selective autophagy: focus on BAG proteins.

Authors:  Martin Gamerdinger; Serena Carra; Christian Behl
Journal:  J Mol Med (Berl)       Date:  2011-08-05       Impact factor: 4.599

6.  PI31 Is an Adaptor Protein for Proteasome Transport in Axons and Required for Synaptic Development.

Authors:  Kai Liu; Sandra Jones; Adi Minis; Jose Rodriguez; Henrik Molina; Hermann Steller
Journal:  Dev Cell       Date:  2019-07-18       Impact factor: 12.270

7.  Rhes, a striatal-selective protein implicated in Huntington disease, binds beclin-1 and activates autophagy.

Authors:  Robert G Mealer; Alexandra J Murray; Neelam Shahani; Srinivasa Subramaniam; Solomon H Snyder
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

8.  Coordinated processing of 3' slipped (CAG)n/(CTG)n hairpins by DNA polymerases β and δ preferentially induces repeat expansions.

Authors:  Nelson L S Chan; Jinzhen Guo; Tianyi Zhang; Guogen Mao; Caixia Hou; Fenghua Yuan; Jian Huang; Yanbin Zhang; Jianxin Wu; Liya Gu; Guo-Min Li
Journal:  J Biol Chem       Date:  2013-04-12       Impact factor: 5.157

9.  Age-dependent decrease in chaperone activity impairs MANF expression, leading to Purkinje cell degeneration in inducible SCA17 mice.

Authors:  Su Yang; Shanshan Huang; Marta A Gaertig; Xiao-Jiang Li; Shihua Li
Journal:  Neuron       Date:  2014-01-22       Impact factor: 17.173

10.  Immunoproteomic analysis of potential serum biomarker candidates in human glaucoma.

Authors:  Gülgün Tezel; Ivey L Thornton; Melissa G Tong; Cheng Luo; Xiangjun Yang; Jian Cai; David W Powell; Joern B Soltau; Jeffrey M Liebmann; Robert Ritch
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-13       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.